<?xml version="1.0" encoding="UTF-8"?>
<p id="par0145" class="p">Regarding the examined liver sections of BPA
 <sup class="sup">'</sup>s treated mice; it revealed marked congestion of the hepatic blood vessels as well as marked hepatocytes vacuolar degeneration with many necrotic cells which appeared either with pyknotic nuclei or without any nuclear structure (
 <xref rid="fig0010" ref-type="fig" class="xref">Fig. 2</xref>B and C). On the other hand, liver histopathological examination of PSO
 <sup class="sup">'</sup>s treated mice for 28 successive days before BPA treatment showed good protection against BPA
 <sup class="sup">'</sup>s hepatic cellular alteration. It revealed only mild vacuolar degeneration of the hepatocytes with some necrotic cells (
 <xref rid="fig0010" ref-type="fig" class="xref">Fig. 2</xref>D). In regards to liver of PSO and BPA co-treated mice, it showed centrilobular degeneration and necrosis of the hepatocytes with appearance of increased number of binucleated cells and karyomegaly of some cells (
 <xref rid="fig0010" ref-type="fig" class="xref">Fig. 2</xref>E). While, the hepatic tissue of PSO
 <sup class="sup">'</sup>s treated mice for 28 successive days after BPA treatment showed moderated degree of granular degeneration and scattered necrotic hepatocytes (
 <xref rid="fig0010" ref-type="fig" class="xref">Fig. 2</xref>F).
</p>
